Carol Thomas Daily

As Galapagos pivots its strategy, it brings in a new HR chief to build the high-performing culture crucial for its next chapter of innovation.

Gubernatorial hopeful Mandela Barnes faces a 'no sugar-coating' interview with Jay Walker. Can this podcast moment redefine his campaign for Wisconsin?

TNS Associates marks its 43rd anniversary with a local ranking, shining a light on Denver's booming estate planning market and modern business awards.

Designer Rebecca Minkoff launches her debut footwear line and a new RM Studio collection on QVC, deepening a strategic partnership in the live shopping space.

Newly published research brings scientific rigor to the controversial kratom plant, influencing policy from the FDA to statehouses across the nation.

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

Seven Colombian designers are captivating Paris Fashion Week, weaving ancestral craft and modern style into a strategic play for global economic recognition.

Amid dire therapist shortages and post-pandemic needs, Kelly Education launches Kelly Pediatric Therapy, aiming to fix a broken system for children's care.

The green builder secured its Nasdaq status, but a sharp stock drop reveals market skepticism. Can its $78.5M pipeline convince cautious investors?

As a deadly superbug spreads, BioVersys's BV100 enters late-stage trials, backed by promising data and a novel scientific approach to combat resistance.

As AI fuels explosive data center growth, the industry defends its reliance on diesel generators, citing strict rules and a critical need for backup power.

Trader Interactive and Roamly are embedding AI insurance into RV Trader, Cycle Trader, and Boatmart, making coverage instant and seamless for buyers.

With promising clinical data for its heart disease treatments, Lexeo Therapeutics aims to capture investor attention at the upcoming Leerink conference.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.

Publishing giant convenes leaders to define standards for adaptive knowledge, tackling IP, trust, and the very future of reading in the age of AI.

A major contract with HawkEye 360 signals Europe's urgent push for sovereign defense, using commercial satellites to monitor invisible threats from space.

Flare Therapeutics partners with Simplicis, moving from manual "human babysitting" to automated infrastructure to eliminate risk and scale drug discovery.

A free service has checked for vehicle recalls 10 billion times, yet millions of drivers remain on the road with dangerous, unfixed safety defects.

The firm's Mexican affiliate begins import permit registration, signaling a strategic move to unlock cross-border trade and near-shoring manufacturing.